These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4547478)

  • 21. [Diagnosis and treatment of the thrombohemorrhagic syndrome].
    Dubiaga AN; Zigan'shin RV; Tsushko VS
    Khirurgiia (Mosk); 1985 Dec; (12):67-71. PubMed ID: 4087752
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of intravenous administration of polyvinol on the state of the coagulation and fibrinolytic blood system in hypofibrinogenemia].
    Chernaia VV
    Probl Gematol Pereliv Krovi; 1968 May; 13(5):16-9. PubMed ID: 5307305
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of heparin and AMCA on coagulation and fibrinolysis in blood and lymph following massive haemorrhage in dogs.
    Leandoer L; Bergentz SE; Nilsson IM
    Acta Chir Scand; 1969; 135(1):1-6. PubMed ID: 5805939
    [No Abstract]   [Full Text] [Related]  

  • 24. [The significance of blood coagulation in the pathogenesis of acute experimental pneumonias].
    Patrushev VI; Shekhtman MA
    Biull Eksp Biol Med; 1973 May; 75(5):30-3. PubMed ID: 4778681
    [No Abstract]   [Full Text] [Related]  

  • 25. [Coagulation inhibiting effect of Trasylol].
    Slunsky R
    Z Geburtshilfe Gynakol; 1971 Aug; 175(1):55-61. PubMed ID: 5315177
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of placentin-3--a new preparation from human placental tissue--on the blood coagulating system].
    Limvinov VV
    Biull Eksp Biol Med; 1969 Feb; 67(2):19-21. PubMed ID: 5821421
    [No Abstract]   [Full Text] [Related]  

  • 27. Coagulation changes induced by endotoxin and purified contact activation product.
    Barth P; Zimmermann R
    Thromb Diath Haemorrh; 1972 Oct; 28(2):280-8. PubMed ID: 4639660
    [No Abstract]   [Full Text] [Related]  

  • 28. Postpartum management of women at increased risk of thrombosis--results of a Canadian pilot survey.
    Spitzer KA; Murphy K; Crowther M; Clark CA; Laskin CA
    J Rheumatol; 2006 Nov; 33(11):2222-6. PubMed ID: 16981294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinogen turnover during the administration of high phospholipidic content placental extracts.
    Casale G; Ricotti MP; Caliandro LP
    Farmaco Prat; 1977 Jun; 32(6):312-7. PubMed ID: 872919
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hematological changes related to coagulation in toxemia of pregnancy --in reference to postpartum hemorrhage (author's transl)].
    Fuse Y; Shirai T
    Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):506-12. PubMed ID: 6972144
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrinogen after massive haemorrhage. Studies on coagulation and fibrinolysis of blood and lymph in dogs.
    Leandoer L
    Acta Chir Scand Suppl; 1968; 390():1-20. PubMed ID: 5275171
    [No Abstract]   [Full Text] [Related]  

  • 32. Portal vein thrombosis associated with pregnancy. A case report.
    Goodrich MA; James EM; Baldus WP; Lomboy CT; Harms RW
    J Reprod Med; 1993 Dec; 38(12):969-72. PubMed ID: 8120856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on the influence of secale derivatives on blood coagulation].
    Zürn H; Gruhle E; Jährig S
    Dtsch Gesundheitsw; 1970 Sep; 25(37):1754-7. PubMed ID: 5312590
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of protamine sulfate on blood coagulation in intravenous administration of placental extract].
    Skipetrov VP
    Patol Fiziol Eksp Ter; 1966; 10(4):69-70. PubMed ID: 5237748
    [No Abstract]   [Full Text] [Related]  

  • 35. Hemophilia-like postpartum bleeding.
    Greenwood RJ; Rabin SC
    Obstet Gynecol; 1967 Sep; 30(3):362-6. PubMed ID: 5298589
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of oxytocin on the coagulating properties of the blood and on the thrombocyte formation activation processes by placental tissue activators during labor].
    Susloparov LA
    Vopr Okhr Materin Det; 1973; 18(4):72-7. PubMed ID: 4802777
    [No Abstract]   [Full Text] [Related]  

  • 37. [Thrombohemorrhagic syndrome in oncological patients].
    Pavlovskiĭ DP
    Klin Med (Mosk); 1981 May; 59(5):16-20. PubMed ID: 7022006
    [No Abstract]   [Full Text] [Related]  

  • 38. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 39. [New approaches in the diagnosis of thrombosis and arteriosclerosis by the use of radioactive lytic and coagulating substances].
    Bogoliubov VM
    Vestn Akad Med Nauk SSSR; 1967; 22(4):43-8. PubMed ID: 4238783
    [No Abstract]   [Full Text] [Related]  

  • 40. Thrombogenicity of heparin and non-heparin bound arterial prostheses: an in vitro evaluation.
    Mohamed MS; Mukherjee M; Kakkar VV
    J R Coll Surg Edinb; 1998 Jun; 43(3):155-7. PubMed ID: 9654873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.